OR WAIT null SECS
February 01, 2018
Cambrex invests in development and laboratory facilities and adds staff.
Avista Pharma's strengthens early phase drug development offerings with acquisition of Solid Form Solutions.
January 16, 2018
A ceremony was held at Cambrex’s Karlskoga facility to mark the commencement of a long-term manufacturing agreement with AstraZeneca for a key intermediate.
January 02, 2018
FDA looks to achieve near-record level of new drug approvals following slowdown in 2016.
December 18, 2017
MJR PharmJet's MicroJet Reactor technology is a continuous process for producing nanoparticles with tightly controlled particle size and particle size distribution.
December 02, 2017
For many processes involving hazardous chemistry, running in flow mode has safety and economic advantages.
November 20, 2017
Avista Pharma Solutions facility and equipment upgrades at its Longmont, Colorado facility support processing of potent compounds.
October 17, 2017
CordenPharma will expand development capacity for small molecules, peptides, and carbohydrates at its Liestal, Switzerland site
September 26, 2017
Additional reactor capacity and a wastewater processing plant increase API manufacturing capacity at the Cambrex site in Kalskoga, Sweden.
September 25, 2017
BASF will build a new specialty amines plant at its existing wholly owned site in Nanjing Chemical Industry Park in China.